Abstract:OBJECTIVE:To measure the urokinase-type plasminogen activator (UPA) and its receptor (UPAR) in the plasma of patients with cerebral infarction and to study the effects of UPA and UPAR on cerebral infarction.METHODS:ELISA sandwich method was used to measure the plasma levels of UPA and UPAR in 89 patients with acute cerebral infarction, subdivided into mild, moderate and severe subgroups according to the modified Edinburgh-Scandinavia stroke scale (mESSS), and 30 patients with other disease and 30 healthy persons as controls.RESULTS:Within 2 days after the onset of cerebral infarction the UPA and UPAR levels were (1663.7 +/- 384.2) ng/L and (1 375.3 +/- 303.0) ng/L respectively, both significantly higher than those of the patients with other diseases [(1 033.0 +/- 122.7) ng/L and (978.3 +/- 120.0) ng/L respectively (P = 0.038 and P = 0.000)] and those of the normal control group [(1 005.0 +/- 128.9) ng/L and (904.7 +/- 158.6) ng/L respectively, both P = 0.000]. Two weeks after the onset of stroke, the plasma UPA level was (1 185.5 +/- 384.6) ng/L, not significantly different from those of the 2 control groups (both P > 0.05); while the plasma UPAR level in the cerebral infarction was (1 159.3 +/- 261.2) ng/L, significantly higher than those in the 2 control groups (P < 0.01). Within 2 days after the onset of infarction the plasma UPA and UPAR levels of the severe subgroup were (1 938.9 +/- 256.5) ng/L and (1 510.8 +/- 378.7) ng/L respectively, both significantly higher than those of the moderate subgroup [(1 593.7 +/- 204.8) ng/L and (1 296.6 +/- 151.2) ng/L respectively, both P < 0.01] and those of the mild subgroup [1 358.5 +/- 175.9] ng/L and (1 226.8 +/- 98.3) ng/L respectively, both P < 0.01], Two weeks after the onset of stroke,the plasma UPA and uPAR levels of the severe subgroup remained significantly higher than those of the mild subgroup [(1 152.6 +/- 170.3) ng/L vs (1 041.9 +/- 187.0) ng/L, (P < 0.05)] and [(1 186.4 +/- 158.3) ng/L vs (1 053.9 +/- 109.4) ng/L, (P < 0.01)]. In addition, the plasma UPA and UPAR levels of the patients who died from cerebral infarction at last were the highest among all the groups.CONCLUSION:The plasma levels pf UPA and UPAR increase in patients with cerebral infarction and may be related with the severity of disease. The UPA and UPAR genes may play an important role via proteolytic degradation of the extracellular matrix and basement membrane during the development of cerebral infarction.

Change of plasma urokinase type plasminogen activator and its receptor in patients with acute pancreatitis

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

Changes of Homocysteine, Endothelin and Von Willebrand Factor in Patients with Angina Pectoris

Importance of Fibrinolytic Activity in Patients with Coronary Artery Diseases

Effects of Carvedilol on Homocysteine,endothelin and Von Willebrand Factor in Patients with Unstable Angina Pectoris

The Relationship of Homocysteine Levels to Tissue Plasminogen Activator and Plasminogen Activator Inhibitor in Acute Coronary Syndrome Patients

Study in the relationship between severity of coronary artery disease and high sensitive-C reaction protein as well as insulin resistance

[Expression of Urokinase-Type Plasminogen Activator and Its Receptor in Plasma of Patients with Cerebral Infarction].

Changes in serum levels of M30, M65, and IL-17 and their clinical significance in patients with acute pancreatitis

Changes and clinical significance of D- dimer and protein kinase C activities of lymphocytes in peripheral blood in the patients with acute pancreatitis

Relationship Between Serum Procalcitonin，high Mobility Group Box Chromoso(m)al Protein 1 Levels and Severity and Prognosis of Acute Pancreatitis

Analysis of early risk factors associated with the outcome of severe acute pancreatitis

Changes of Plasma P-selectin、 Thrombomodulin、 Plasminogen Activator Inhibitor-1 of Coronary Artery Disease Patients Before and after PTCA

Serum uric acid concentration in acute pancreatitis is significantly higher than healthy population

Levels of Procalcitonin in Blood and Tissue of Acute Pancreatitis Rats

Changes of serum level of IL-15, IL-18 and sTNF-1R in patients with acute pancreatitis

Detection of Plasma Urokinase-Type Plasminogen Activator and Its Receptor in Acute or Chronic Hepatitis B Patients and Its Clinical Significance

Alteration at Coagulation Function in Patients with Severe Acute Pancreatitis

The relation between CRP and lipid in patients with acute coronary syndrome and its clinic value

Changes and Significance of T Lymphocyte Subsets and C-reactive Protein of Acute Pancreatitis in Acute Reaction Period

Cardiac troponin I in acute pancreatitis patients and its influencing factors